Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II-Associated Non-Islet Cell Tumor Hypoglycemia

Okazaki-Hada, Mikiko ; Nagao, Mototsugu LU ; Asai, Akira LU ; Okada-Iwabu, Miki ; Hizuka, Naomi ; Eliasson, Lena LU orcid ; Sugihara, Hitoshi ; Fukuda, Izumi and Iwabu, Masato (2025) In Journal of Clinical Endocrinology and Metabolism 110(9). p.3063-3069
Abstract

Context In most cases of non-islet cell tumor hypoglycemia (NICTH), high molecular weight forms of insulin-like growth factor II, commonly referred to as big IGF-II, cause hypoglycemia. MicroRNA-483 (miR-483), encoded within an intron of IGF2, has been suggested to be coexpressed with IGF-II. Objective The aim of this study is to demonstrate the utility and reliability of circulating miR-483 as a biomarker for diagnosis and therapeutic outcome of NICTH. Methods Sera from 145 cases of suspected NICTH, and postoperative sera from 25 surgical cases of confirmed NICTH were subjected to Western blot analysis and enzyme-linked immunosorbent assay for IGF-II and quantitative polymerase chain reaction analysis for miR-483-5p and -3p. Tissue... (More)

Context In most cases of non-islet cell tumor hypoglycemia (NICTH), high molecular weight forms of insulin-like growth factor II, commonly referred to as big IGF-II, cause hypoglycemia. MicroRNA-483 (miR-483), encoded within an intron of IGF2, has been suggested to be coexpressed with IGF-II. Objective The aim of this study is to demonstrate the utility and reliability of circulating miR-483 as a biomarker for diagnosis and therapeutic outcome of NICTH. Methods Sera from 145 cases of suspected NICTH, and postoperative sera from 25 surgical cases of confirmed NICTH were subjected to Western blot analysis and enzyme-linked immunosorbent assay for IGF-II and quantitative polymerase chain reaction analysis for miR-483-5p and -3p. Tissue miR-483 expression levels were compared between resected solitary fibrous tumors (SFTs) and their surrounding margins from 11 surgical cases. Results NICTH was confirmed in 100 out of 145 cases based on the detection of big IGF-II in their sera. Receiver operating characteristic curve analysis revealed that serum miR-483-5p had a better diagnostic ability for NICTH than serum IGF-II or the classical diagnostic marker the IGF-II to IGF-I ratio. Notably, serum miR-483-5p levels decreased significantly with the disappearance of big IGF-II after surgical tumor resection. Tissue miRNA-483-5p and -3p expression levels were significantly higher in resected SFT tissues than in their surgical margins. Conclusion Circulating miR-483-5p, derived from IGF-II-producing tumors, appears to be a more reliable biomarker for diagnosis and therapeutic outcome of NICTH than IGF-II or the IGF-II to IGF-I ratio. These findings highlight the clinical utility of miR-483-5p in the management of NICTH.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
IGF-II, MicroRNA, Non-islet cell tumor hypoglycemia
in
Journal of Clinical Endocrinology and Metabolism
volume
110
issue
9
pages
3063 - 3069
publisher
Oxford University Press
external identifiers
  • scopus:105013194122
  • pmid:39689018
ISSN
0021-972X
DOI
10.1210/clinem/dgae879
language
English
LU publication?
yes
id
0e311363-8b1f-4ce5-a40d-fbce4b96e2cb
date added to LUP
2025-10-20 12:10:51
date last changed
2025-11-17 14:12:23
@article{0e311363-8b1f-4ce5-a40d-fbce4b96e2cb,
  abstract     = {{<p>Context In most cases of non-islet cell tumor hypoglycemia (NICTH), high molecular weight forms of insulin-like growth factor II, commonly referred to as big IGF-II, cause hypoglycemia. MicroRNA-483 (miR-483), encoded within an intron of IGF2, has been suggested to be coexpressed with IGF-II. Objective The aim of this study is to demonstrate the utility and reliability of circulating miR-483 as a biomarker for diagnosis and therapeutic outcome of NICTH. Methods Sera from 145 cases of suspected NICTH, and postoperative sera from 25 surgical cases of confirmed NICTH were subjected to Western blot analysis and enzyme-linked immunosorbent assay for IGF-II and quantitative polymerase chain reaction analysis for miR-483-5p and -3p. Tissue miR-483 expression levels were compared between resected solitary fibrous tumors (SFTs) and their surrounding margins from 11 surgical cases. Results NICTH was confirmed in 100 out of 145 cases based on the detection of big IGF-II in their sera. Receiver operating characteristic curve analysis revealed that serum miR-483-5p had a better diagnostic ability for NICTH than serum IGF-II or the classical diagnostic marker the IGF-II to IGF-I ratio. Notably, serum miR-483-5p levels decreased significantly with the disappearance of big IGF-II after surgical tumor resection. Tissue miRNA-483-5p and -3p expression levels were significantly higher in resected SFT tissues than in their surgical margins. Conclusion Circulating miR-483-5p, derived from IGF-II-producing tumors, appears to be a more reliable biomarker for diagnosis and therapeutic outcome of NICTH than IGF-II or the IGF-II to IGF-I ratio. These findings highlight the clinical utility of miR-483-5p in the management of NICTH.</p>}},
  author       = {{Okazaki-Hada, Mikiko and Nagao, Mototsugu and Asai, Akira and Okada-Iwabu, Miki and Hizuka, Naomi and Eliasson, Lena and Sugihara, Hitoshi and Fukuda, Izumi and Iwabu, Masato}},
  issn         = {{0021-972X}},
  keywords     = {{IGF-II; MicroRNA; Non-islet cell tumor hypoglycemia}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{3063--3069}},
  publisher    = {{Oxford University Press}},
  series       = {{Journal of Clinical Endocrinology and Metabolism}},
  title        = {{Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II-Associated Non-Islet Cell Tumor Hypoglycemia}},
  url          = {{http://dx.doi.org/10.1210/clinem/dgae879}},
  doi          = {{10.1210/clinem/dgae879}},
  volume       = {{110}},
  year         = {{2025}},
}